Papers - TAKAHATA Takenori
-
Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma
Takenori Niioka, Tsukasa Uno, Norio Yasui-Furukori, Takenori Takahata, Mikiko Shimizu, Kazunobu Sugawara, Tomonori Tateishi
CANCER CHEMOTHERAPY AND PHARMACOLOGY 59 ( 5 ) 575 - 580 2007.4
-
A CASE OF MANTLE CELL LYMPHOMA WITH EARLY GASTRIC CANCER
HANABATA Norihiro, MIKAMI Tatsuya, FUKUDA Shinsaku, NISHIYA Daisuke, SASAKI Satoshi, TAKAHATA Takenori, ITOH Jugoh, SASAKI Yoshihiro, KIJIMA Hiroshi, MUNAKATA Akihiro
GASTROENTEROLOGICAL ENDOSCOPY 49 ( 7 ) 1674 - 1680 2007
-
The influence of methylated p15INK4b and p16INK4a genes on clinicopathological features in colorectal cancer
Atsushi Ishiguro, Takenori Takahata et al
Journal of Gastroenterology and Hepatology 21 ( 8 ) 1334 - 1339 2006.4
-
経過中にmultiple lymphomatous polyposisを大腸に認めた悪性リンパ腫の一例
吉谷元、鈴木一広、高畑武功、他
青森県立中央病院医誌 51 ( 4 ) 126 - 131 2006.4
-
日本人高齢者におけるCYP2C19変異遺伝子頻度とオメプラゾール薬物動態を指標とした生体内CYP2C19活性の検討
石澤幸男、高畑武功、他
臨床薬理の進歩 ( 27 ) 82 - 87 2006.4
-
Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotype
Mikiko Shimizu,Takenori Takahata et al
Journal of Chromatography B Amalyt Technol Biomed Life Science 832 ( 2 ) 241 - 218 2006.4
-
Lack of significant effect of grapefruit juice on the pharmacokinetics of lansoprazole and its metabolites in subjects with different CYP2C19 genotypes.
Uno T, Yasui-Furukori N, Takahata T, Sugawara K, Tateishi T
Journal of clinical pharmacology 45 ( 6 ) 690 - 4 2005.6
-
S-1/CDDP併用化学療法が奏功した進行低分化型胃癌の1例
佐々木聡、高畑武功,他
青森県立中央病院医誌 50 ( 4 ) 137 - 141 2005.4
-
露出腫瘤型乳頭癌の診断にて切除後、病理学的検索にて膵頭部癌と診断された1例の考察
加藤幸三、須藤晃司、高畑武功 他
弘前市立病院医誌 14 ( 1 ) 19 - 24 2005.4
-
合流部結石の2症例
木村由佳、須藤晃司,高畑武功 他
弘前市立病院医誌 14 ( 1 ) 25 - 29 2005.4
-
C型慢性肝炎にみられたhypovascularな脂肪原性肝腫瘍の1例
高畑武功、須藤晃司,他
弘前市立病院医誌 14 ( 1 ) 35 - 40 2005.4
-
The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics
Yukio Ishizawa, Norio Yasui-Furukori, Takenori Takahata et al
Clin Pharmacokinet 44 ( 11 ) 1179 - 1189 2005.4
-
Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta1-blocker
Takenori Takahata et al
Drugs RD 6(6) 385 - 394 2005.4
-
Lack of significant effect of grapefruit juice on the pharmacokinetics of lansoprazole and itsmetabolites in subjects with different CYP2C19 genotypes
Tsukasa Uno, Norio Yasui-Furukori, Takenori Takahata et al
Journal of Clinical Pharmacology 45 690 - 694 2005.4
-
Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity
Tsukasa Uno, Norio Yasui-Furukori, Takenori Takahata at al
Journal of Chromatography B 816 309 - 314 2005.4
-
Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes
Masato Saito, Norio Yasui-Furukori, Tsukasa Uno, Takenori Takahata et al
British Journal of Clinical Pharmacology 59 302 - 309 2005.4
-
Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes
M Saito, N Yasui-Furukori, T Uno, T Takahata, K Sugawara, A Munakata, T Tateishi
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 59 ( 3 ) 302 - 309 2005.3
-
The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics.
Ishizawa Y, Yasui-Furukori N, Takahata T, Sasaki M, Tateishi T
Clinical pharmacokinetics 44 ( 11 ) 1179 - 89 2005
-
Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes
N Yasui-Furukori, M Saito, T Uno, T Takahata, K Sugawara, T Tateishi
JOURNAL OF CLINICAL PHARMACOLOGY 44 ( 11 ) 1223 - 1229 2004.11
-
Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes
N Yasui-Furukori, K Mihara, T Takahata, A Suzuki, T Nakagami, R De Vries, T Tateishi, T Kondo, S Kaneko
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 57 ( 5 ) 569 - 575 2004.5